Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-alpha Treatment

Date
2015
Author
Duman, Berna
Musellim, Benan
Mazican, Nejdiye
Hamuryudan, Vedat
Ozguler, Yesim
Ongen, Gul
Atahan, Ersan
Yilmaz, Deniz Demir
Borekci, Sermin
Metadata
Show full item record
Abstract
Background: Tumor necrosis factor (TNF)-alpha inhibitors are known to increase the risk of tuberculosis (TB). Objectives: To examine the factors associated with an increased risk of TB in patients receiving anti-TNF-alpha treatment (aTNF-alpha-T).
URI
http://hdl.handle.net/20.500.12627/41697
https://doi.org/10.1159/000434684
Collections